Catalyst
Slingshot members are tracking this event:
BioMarin to Present Results from Phase 1/2 Study of BMN 190 on CLN2 Disease at 12th Annual WORLDSymposium
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BMRN |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 02, 2016
Occurred Source:
http://investors.bmrn.com/releasedetail.cfm?ReleaseID=958565
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1/2 Data, Bmn 190, Cln2 Disorder
